Award
National Institute of Allergy and Infectious Diseases 11352556
Bloodstream infection detection directly on whole blood
Recipient
SCANOGEN, INC.
Award Amount
$1,000,000.00
Ceiling
$1,000,000.00
Awarded
June 30, 2026
Identifier
11352556
Award to SCANOGEN, INC. for developing an automated molecular diagnostic platform to rapidly detect bloodstream infections from whole blood, focusing on yeast pathogens, with a $1,000,000 award amount.
Description
Development of a fully automated molecular platform for the diagnosis of bloodstream infections directly from whole blood without the need for blood culture. The project aims to develop and validate an assay that can identify a panel of relevant yeasts and broadly detect Candida species with a turnaround time of 1.2 hours, improving rapid identification of yeast pathogens in patients suspected of sepsis.